IASIS PHARMACEUTICALS HELLAS S.A., Pharmaceutical Industry

IASIS PHARMA is a purely Greek pharmaceutical industry, active in the production, research and development, import and marketing of medicines, pharmaceuticals and cosmetics, having its production plant in operation since 1985, in the area of ​​Kamatero, Attica.

IASIS PHARMA serves 2 strategic directions:

Development: medicines that serve specialized therapeutic categories

Research: from the basic ingredients to the final products, the company invests in herbal medicines, recognizing their importance in the prevention and treatment of diseases.

IASIS PHARMA production unit operates under the strictest and most modern production standards cGMP, cGLP, while it is certified by Bureau Veritas with ISO 9001: 2015 (Quality Management System). The unit has an operating license from the Greek National Organization for Medicines (EOF), while it has been inspected by Medicines Organizations of other countries, resulting in being considered suitable for the certification of analytical methods.

Furthermore, in recent years IASIS PHARMA holds the production and commercial promotion within the medical community and pharmacies, of an OTC pharmaceutical product in the form of a 350 mg capsule, indicated for the gastrointestinal system. This product’s active substance, Chios mastic, is supplied as a raw material by Chios Gum Mastic Growers Association.

In 2016, in pursuance to meet the ever-increasing production needs both for the greek and -mainly- for the foreign market, IASIS PHARMA proceeded to acquire a new ownership. This property is located within the Industrial Zone of Koropi, Attica and has an area of ​​42 acres. It has building facilities with industrial specifications of an area of ​​about 9 acres, where the construction of new modern Facilities takes place, including three dedicated and separated Production Facilities, Logistics & Distribution Center, as well as a fully equipped Research & Development Center.